Aktionsbündnis Allergieprävention , Luebeck

Allergies are a meaningful public-health problem. Until now, no evidence-based recommendations for allergy prevention exist. An evidence based guideline for primary and secondary prevention of allergies was developed in the course of the "Aktionsbündnis Allergieprävention” (abap; with a grant of the German Ministry of Health). Results of the systematic evidence search and the consented recommendations are presented here.

After an appropriate search strategy had been developed, a systematic literature search was performed in electronic databases (Cochrane library, MEDLINE, EMBASE). Furthermore four selected journals were hand-searched and reference lists of recent reviews as well as "grey literature" was screened. Some 3,500 references were retrieved initially, and a two-stage filter process on the relevance was applied by screening titles and abstracts and subsequently full-text papers. For the critical methodological appraisal, modifications of international checklists were used. A total of 323 studies were included and evaluated. These comprised 3 Cochrane Reviews, 7 meta-analyses, 36 randomized controlled trials (RCTs) as well as 102 cohort and 174 case-control-studies. The following levels of evidence were applied: 3x1a, 21x1b, 5x2a, 59x2b, 1x3a, 45x3b, 189x4. These studies were summarized in a form of a systematic review, and corresponding recommendations were formulated. The latter were consented by members of the abap steering committee in two consensus meetings, where the method of a nominal group process was applied. For the first time, recommendations for the prevention of allergies were developed on a high methodological standard. The content and modifications reflect the existing evidence.

Key words: guideline/ allergy/ prevention/ evidence/ evidence based medicine

Sie finden den Artikel in deutscher Sprache in Ernährungs-Umschau 09/04 ab Seite 361.



Aktionsbündnis Allergieprävention , Luebeck

Allergies are a meaningful public-health problem. Until now, no evidence-based recommendations for allergy prevention exist. An evidence based guideline for primary and secondary prevention of allergies was developed in the course of the "Aktionsbündnis Allergieprävention” (abap; with a grant of the German Ministry of Health). Results of the systematic evidence search and the consented recommendations are presented here.

After an appropriate search strategy had been developed, a systematic literature search was performed in electronic databases (Cochrane library, MEDLINE, EMBASE). Furthermore four selected journals were hand-searched and reference lists of recent reviews as well as "grey literature" was screened. Some 3,500 references were retrieved initially, and a two-stage filter process on the relevance was applied by screening titles and abstracts and subsequently full-text papers. For the critical methodological appraisal, modifications of international checklists were used. A total of 323 studies were included and evaluated. These comprised 3 Cochrane Reviews, 7 meta-analyses, 36 randomized controlled trials (RCTs) as well as 102 cohort and 174 case-control-studies. The following levels of evidence were applied: 3x1a, 21x1b, 5x2a, 59x2b, 1x3a, 45x3b, 189x4. These studies were summarized in a form of a systematic review, and corresponding recommendations were formulated. The latter were consented by members of the abap steering committee in two consensus meetings, where the method of a nominal group process was applied. For the first time, recommendations for the prevention of allergies were developed on a high methodological standard. The content and modifications reflect the existing evidence.

Key words: guideline/ allergy/ prevention/ evidence/ evidence based medicine

Sie finden den Artikel in deutscher Sprache in Ernährungs-Umschau 09/04 ab Seite 361.

Evidence-based and consented guideline on allergy prevention

Aktionsbündnis Allergieprävention , Luebeck

Allergies are a meaningful public-health problem. Until now, no evidence-based recommendations for allergy prevention exist. An evidence based guideline for primary and secondary prevention of allergies was developed in the course of the “Aktionsbündnis Allergieprävention” (abap; with a grant of the German Ministry of Health). Results of the systematic evidence search and the consented recommendations are presented here.

After an appropriate search strategy had been developed, a systematic literature search was performed in electronic databases (Cochrane library, MEDLINE, EMBASE). Furthermore four selected journals were hand-searched and reference lists of recent reviews as well as “grey literature” was screened. Some 3,500 references were retrieved initially, and a two-stage filter process on the relevance was applied by screening titles and abstracts and subsequently full-text papers. For the critical methodological appraisal, modifications of international checklists were used. A total of 323 studies were included and evaluated. These comprised 3 Cochrane Reviews, 7 meta-analyses, 36 randomized controlled trials (RCTs) as well as 102 cohort and 174 case-control-studies. The following levels of evidence were applied: 3x1a, 21x1b, 5x2a, 59x2b, 1x3a, 45x3b, 189×4. These studies were summarized in a form of a systematic review, and corresponding recommendations were formulated. The latter were consented by members of the abap steering committee in two consensus meetings, where the method of a nominal group process was applied. For the first time, recommendations for the prevention of allergies were developed on a high methodological standard. The content and modifications reflect the existing evidence.

Key words: guideline/ allergy/ prevention/ evidence/ evidence based medicine

Sie finden den Artikel in deutscher Sprache in Ernährungs-Umschau 09/04 ab Seite 361.

Artikelfakten

Rubrik: Summaries
Veröffentlicht: 14.09.2004

Dieser Artikel erscheint in

Artikel teilen

Weitere Artikel zum Thema

Keine Ergebnisse gefunden

Die angefragte Seite konnte nicht gefunden werden. Verfeinern Sie Ihre Suche oder verwenden Sie die Navigation oben, um den Beitrag zu finden.